Sign in

You're signed outSign in or to get full access.

Mark Bolus

About Mark J. Bolus

Independent director since 2010; age 59. President & CEO of Bolus Motor Lines, Inc. and Bolus Freight Systems, Inc., bringing ~30 years of management experience in freight transportation with real estate expertise and deep knowledge of Upstate NY and Northeast PA markets critical to CBU’s footprint . Determined independent under NYSE and company guidelines; the Board lists him among 11 of 12 independent nominees .

Past Roles

OrganizationRoleTenureCommittees/Impact
Bolus Motor Lines, Inc.President & CEO~30 yearsOperates across Northeast/Midwest/Mid-Atlantic; provides economic insight in CBU markets; real estate experience
Bolus Freight Systems, Inc.President & CEO~30 yearsSame as above; supplements Board’s understanding of regional business conditions

External Roles

OrganizationRoleTenureCommittees/Impact
None disclosed (public company boards)No other public company directorships disclosed in latest proxy

Board Governance

  • Committee memberships: Compensation Committee Chair; Executive Committee member; Risk Committee member; Trust Committee member .
  • Committee cadence: Compensation (5 regular, 2 special in 2024); Executive (3 regular); Risk (5 meetings; entire Board); Trust (4 meetings) .
  • Independence: Listed as independent; Board comprises 11 of 12 independent nominees .
  • Attendance: Board held 9 regular meetings in 2024; every director attended at least 75% of Board and committee meetings; all directors attended the May 15, 2024 annual meeting .
  • Election results (2025): For 39,605,216; Against 659,090; Abstain 311,866; Broker non-votes 5,176,446 .
  • Policies: Majority voting standard for uncontested elections; independent Chair; regular executive sessions of independent directors .

Fixed Compensation

Metric20232024
Fees Earned or Paid in Cash ($)$85,000 $87,500
Annual Equity Award – Deferred Stock Units (Grant-date Fair Value $)$62,385; grant vested Mar 13, 2023 $61,800; grant vested Mar 19, 2024
  • Retainer structure as of July 1, 2024 (for context): Board member $65,000; Compensation Chair $15,000; Executive member $5,000; Trust member $5,000; Risk member none; Board Chair $120,000; Audit Chair $22,500; Governance Chair $15,000; Equity grant to be increased by $7,615 starting March 2025 .
  • Directors may defer cash fees into share-equivalent units; current participants listed (Bolus not among 2024–2025 deferrers of cash fees) .

Performance Compensation

  • Directors receive annual equity in the form of deferred stock units (DSUs) tracking CBU’s share price; DSUs must be deferred at least one year and are settled in stock on election date (up to 10 years) .
  • No performance-conditioned director equity (e.g., PSUs) disclosed; equity is time/deferred-based, aligning with long-term shareholder value .
Equity Detail20232024
DSU Grant and VestMar 13, 2023; vested Mar 19, 2024; vested
DSUs Outstanding (units)1,886 as of Dec 31, 2023 3,358 as of Dec 31, 2024

Other Directorships & Interlocks

CompanyRoleNotes
None disclosed (public issuers)No compensation committee interlocks or insider participation in 2024; Compensation Committee entirely independent .

Expertise & Qualifications

  • Operating executive with multi-decade freight transportation leadership; brings real estate expertise and market insights across CBU’s geographies .
  • Committee leadership: Compensation Chair; human capital oversight and pay governance responsibilities .

Equity Ownership

Ownership Metric2024 (as of Mar 22, 2024)2025 (as of Mar 24, 2025)
Beneficial Ownership (shares)132,828 134,691
% of Shares Outstanding0.25% 0.25%
Jointly with spouse57,439 60,923
Trustee – Mark Bolus Trust8,074 7,873
Trustee – Austin Bolus Trust5,552 5,750
Trustee – Noah Bolus Trust5,552 5,750
Trustee – Paige Bolus Trust5,552 5,750
Trustee – Taylor Bolus Trust5,552 5,750
Deferred Stock Units Outstanding3,282 (Director DSUs as of Mar 22, 2024) 2,467 (Director DSUs as of Mar 24, 2025)
  • Stock ownership guidelines: Directors must own ≥5× annual base Board retainer within six years; all Directors are in compliance .
  • Hedging/short sales/derivatives prohibited; pledging prohibited absent prior written consent .

Governance Assessment

  • Strengths: Long-tenured independent director with local market expertise; Chairs Compensation Committee with independent membership and use of independent consultant Meridian; robust pay governance (no option repricings; clawbacks for executives; ownership guidelines) .
  • Alignment: Material share ownership (0.25% of outstanding), DSUs outstanding, and ownership guidelines compliance support skin-in-the-game .
  • Engagement signals: Strong re-election support in 2025 vote tallies; high say‑on‑pay support in 2024 (93.15%) and substantial support in 2025 by raw counts .
  • Potential conflicts: No related-party transactions involving Bolus disclosed; company notes director/officer banking relationships may occur on ordinary-course, market terms; Audit Committee oversees related-party policy . No pledging or hedging disclosures for Bolus .
  • Attendance: Met governance threshold (≥75% of meetings) in 2024; participated across multiple committees .

Note: We attempted to locate recent Form 4 insider filings for “Mark J. Bolus” in the system; none were available via our document listing during 2024–2025 (doc type 4 returned 0), so insider trade patterns could not be assessed from SEC Form 4 in this environment [ListDocuments result].

Fixed Compensation (detail)

ComponentDescriptionSource
Board cash retainer$65,000 (member); effective Jul 1, 2024
Committee retainersCompensation Chair $15,000; Executive member $5,000; Trust member $5,000; Risk member none
Annual equity grantDSUs; grant-date fair value increased by $7,615 starting Mar 2025

Performance Compensation (detail)

ComponentDesignVestingSource
Deferred Stock Units (directors)Tracks CBU share price; paid in stock at elected dateDeferral ≥1 year; payout in shares up to 10 years post grant

Say‑on‑Pay & Shareholder Feedback

  • 2024 say‑on‑pay approval: 93.15% support .
  • 2025 say‑on‑pay votes: For 39,208,889; Against 1,232,650; Abstain 134,633; Broker non‑votes 5,176,446 .

Compensation Committee Analysis

  • Members: Bolus (Chair), Fesette, Knauss, Skerritt, Steele; fully independent .
  • Consultant: Meridian Compensation Partners, LLC; independent with no conflicts; advises peer group, governance structure, pay levels .
  • Interlocks: None; no insider participation in 2024 .

Related Party Transactions

  • Policy: Audit Committee administers review/approval; threshold >$120,000; ensure market terms and best interests of company .
  • Disclosures: One employment-related related person (son‑in‑law of a former director) reviewed/approved; no transactions involving Bolus disclosed .

Risk Indicators & Red Flags

  • Hedging/pledging prohibited; no pledging disclosed for Bolus .
  • No option repricing; directors compensated via cash retainer and DSUs; equity grant timing predetermined .
  • Attendance met threshold; no governance red flags disclosed for Bolus .

Compensation Structure Analysis

  • Mix trend: Modest YoY increase in cash ($85,000 → $87,500) and similar equity grant value ($62,385 → $61,800); Board moved to increase cash retainer (+$5k) and equity grant (+$7,615) effective H2 2024/March 2025 to align with peer market levels .
  • Market alignment: Director pay levels calibrated to updated peer group; retains independence and at‑risk equity component via DSUs .

Equity Ownership & Alignment

  • Beneficial ownership increased (132,828 → 134,691 shares) with material joint and trustee holdings; DSU balances outstanding; compliant with ownership guidelines .

Governance Summary

  • As Compensation Chair, Bolus oversees pay risk and human capital; independent committee and consultant support board effectiveness .
  • Voting outcomes and attendance indicate investor confidence and engagement; no related‑party, pledging, or attendance concerns disclosed .